Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Doravirine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck's HIV combo treatment meets efficacy bar in Ph 3 trials
    Merck's HIV combo treatment meets efficacy bar in Ph 3 trials

    20 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/mercks-hiv-combo-treatment-meets-bar-viral-suppression-pair-phase-3-studies

    FIERCE BIOTECH
    20 Dec 2024
    Share Share
    Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine
    Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine

    22 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230222005448/en

    BUSINESSWIRE
    22 Feb 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)
    FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)

    03 Oct 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-delstrigo-doravirine-lamivudine-and-tenofovir-disoproxil-fumarate-27898.pdf

    FDA
    03 Oct 2022
    Share Share
    Merck to start studying lower dose of HIV drug after FDA hold
    Merck to start studying lower dose of HIV drug after FDA hold

    21 Sep 2022

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-start-new-study-low-dose-hiv-drug-after-fdas-hold-2022-09-20/

    REUTERS
    21 Sep 2022
    Share Share
    Merck HIV combo pill compares to existing meds in phase 3 trials
    Merck HIV combo pill compares to existing meds in phase 3 trials

    28 Oct 2021

    // K. LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/merck-close-to-regulatory-filings-for-hiv-treatment-combo-shows-comparable-efficacy-to

    K. LaHucik FIERCEBIOTECH
    28 Oct 2021
    Share Share
    Merck Announces New Analyses Showing Additional Safety & Efficacy for Islatravir
    Merck Announces New Analyses Showing Additional Safety & Efficacy for Islatravir

    06 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200706005105/en

    BUSINESSWIRE
    06 Jul 2020
    Share Share